Delivery Order SPE2DR25D2005-SPE2DR26FE6W4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,403.73 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram/day contraceptive patches (3-pack) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,083.55 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,441.54 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack). This firm fixed-price, non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,888.42 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive transdermal patch. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,212.16 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/day contraceptive patches (three-unit supply). This firm fixed-price delivery order was competitively awarded without any set-aside designation and is scheduled for completion by October 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,289.72 on September 26, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (three-count unit) on August 5, 2025. This firm fixed price, non-set-aside delivery order is positioned for ultimate completion by August 6, 2025, with performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,016.43 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-month supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6W4Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,968.04 delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (quantity: 3 units) on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price contract was awarded competitively without set-aside designations and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare systems. Through its DLA prime contract, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for hormonal contraceptive patches represents one of numerous small-value transactions the company fulfills under its broader master contract to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/14/25 |